Walleye Capital’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21.6M Sell
155,300
-29,300
-16% -$4.1M 0.09% 169
2025
Q4
$22.7M Buy
184,600
+93,400
+102% +$11.4M 0.07% 257
2025
Q3
$10.1M Sell
91,200
-53,700
-37% -$6.1M 0.04% 543
2025
Q2
$16.1M Sell
144,900
-40,800
-22% -$4.34M 0.06% 315
2025
Q1
$20.8M Sell
185,700
-28,400
-13% -$2.93M 0.09% 187
2024
Q4
$19.8M Buy
214,100
+148,700
+227% +$13.4M 0.05% 336
2024
Q3
$5.48M Sell
65,400
-5,000
-7% -$382K 0.01% 1113
2024
Q2
$4.83M Sell
70,400
-49,800
-41% -$3.32M 0.01% 1317
2024
Q1
$8.8M Sell
120,200
-124,700
-51% -$9.59M 0.02% 908
2023
Q4
$19.8M Buy
244,900
+81,600
+50% +$6.35M 0.04% 334
2023
Q3
$12.2M Buy
163,300
+68,700
+73% +$5.28M 0.03% 464
2023
Q2
$7.29M Buy
94,600
+35,000
+59% +$2.79M 0.03% 545
2023
Q1
$4.95M Buy
59,600
+32,900
+123% +$2.72M 0.07% 327
2022
Q4
$2.29M Buy
26,700
+8,800
+49% +$697K 0.04% 513
2022
Q3
$1.1M Buy
+17,900
New +$1.13M 0.02% 906
2020
Q2
Sell
-10,500
Closed -$785K 746
2020
Q1
$785K Sell
10,500
-40,900
-80% -$2.83M 0.17% 161
2019
Q4
$3.34M Sell
51,400
-100,300
-66% -$6.53M 0.22% 96
2019
Q3
$9.62M Buy
151,700
+128,700
+560% +$8.41M 0.57% 16
2019
Q2
$1.55M Sell
23,000
-13,800
-38% -$908K 0.17% 156
2019
Q1
$2.39M Buy
+36,800
New +$2.45M 0.39% 19

Other funds holding GILD

Walleye Capital's GILD Position: Q1 2026 in Review

Walleye Capital increased its Gilead Sciences (GILD) stake by 552% in Q1 2026, buying an estimated $17.9M and bringing the position to 150,967 shares worth $21M. The position accounts for 0.09% of the portfolio, ranked #179.

Walleye Capital first reported a position in GILD in Q1 2019 and has held it in 14 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Walleye Capital held 150,967 shares of Gilead Sciences worth $21M as of Q1 2026.
  • Walleye Capital bought 127,817 Gilead Sciences shares in Q1 2026, an estimated $17.9M.
  • Gilead Sciences made up 0.09% of Walleye Capital's portfolio in Q1 2026, its #179 holding.
  • Walleye Capital first reported a position in Gilead Sciences in Q1 2019 and has held it in 14 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.